Ubs Asset Management Americas Inc Elanco Animal Health Inc Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,331,838 shares of ELAN stock, worth $48.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,331,838

Previous 1,793,337 30.03%

Holding current value

$48.2 Million

Previous $18.8 Million 76.83%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.1 - $14.3 $4.36 Million - $7.7 Million	538,501 Added 30.03%	2,331,838 $33.3 Million
Q1 2025 May 19, 2025	BUY	$10.04 - $12.47 $767,136 - $952,807	76,408 Added 4.45%	1,793,337 $18.8 Million
Q4 2024 Feb 14, 2025	BUY	$11.63 - $14.67 $2.4 Million - $3.03 Million	206,482 Added 13.67%	1,716,929 $20.8 Million
Q3 2024 Nov 14, 2024	SELL	$11.85 - $15.47 $525,784 - $686,403	-44,370 Reduced 2.85%	1,510,447 $22.2 Million
Q2 2024 Aug 13, 2024	BUY	$12.93 - $18.45 $9.72 Million - $13.9 Million	751,807 Added 93.62%	1,554,817 $22.4 Million
Q1 2024 May 15, 2024	BUY	$14.37 - $16.46 $82,081 - $94,019	5,712 Added 0.72%	803,010 $13.1 Million
Q4 2023 Feb 14, 2024	BUY	$8.6 - $14.94 $303,038 - $526,440	35,237 Added 4.62%	797,298 $11.9 Million
Q3 2023 Nov 13, 2023	SELL	$9.81 - $12.62 $12.1 Million - $15.6 Million	-1,232,415 Reduced 61.79%	762,061 $8.57 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $77,167 - $127,997	8,779 Added 0.44%	1,994,476 $18.7 Million
Q4 2022 Feb 14, 2023	SELL	$11.49 - $13.65 $933,757 - $1.11 Million	-81,267 Reduced 3.93%	1,985,697 $24.3 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $629,075 - $1.64 Million	-50,691 Reduced 2.39%	2,066,964 $25.7 Million
Q2 2022 Aug 12, 2022	BUY	$19.63 - $26.62 $11.2 Million - $15.1 Million	568,986 Added 36.74%	2,117,655 $41.6 Million
Q1 2022 May 16, 2022	SELL	$24.65 - $29.0 $779,482 - $917,038	-31,622 Reduced 2.0%	1,548,669 $40.4 Million
Q4 2021 Feb 14, 2022	BUY	$27.74 - $34.09 $479,818 - $589,654	17,297 Added 1.11%	1,580,291 $44.8 Million
Q3 2021 Nov 15, 2021	SELL	$29.2 - $36.72 $228,723 - $287,627	-7,833 Reduced 0.5%	1,562,994 $49.8 Million
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $22.4 Million - $28.1 Million	-779,898 Reduced 33.18%	1,570,827 $54.5 Million
Q1 2021 May 14, 2021	BUY	$27.85 - $34.49 $13.8 Million - $17.1 Million	495,943 Added 26.74%	2,350,725 $69.2 Million
Q4 2020 Mar 01, 2021	SELL	$27.53 - $33.79 $16.6 Million - $20.3 Million	-601,800 Reduced 24.5%	1,854,782 $56.9 Million
Q3 2020 Nov 13, 2020	SELL	$21.1 - $29.13 $7.07 Million - $9.77 Million	-335,230 Reduced 12.01%	2,456,582 $68.6 Million
Q2 2020 Aug 14, 2020	SELL	$18.94 - $24.93 $90.1 Million - $119 Million	-4,758,092 Reduced 63.02%	2,791,812 $59.9 Million
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $28.1 Million - $54.4 Million	-1,685,616 Reduced 18.25%	7,549,904 $169 Million
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $55.5 Million - $64.6 Million	2,194,950 Added 31.18%	9,235,520 $272 Million
Q3 2019 Nov 14, 2019	BUY	$25.62 - $34.96 $50.2 Million - $68.4 Million	1,957,520 Added 38.51%	7,040,570 $187 Million
Q2 2019 Aug 15, 2019	BUY	$31.11 - $34.79 $60.6 Million - $67.7 Million	1,947,153 Added 62.09%	5,083,050 $0
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $77.7 Million - $87.9 Million	2,678,700 Added 585.9%	3,135,897 $0
Q4 2018 Feb 13, 2019	BUY	$29.63 - $34.5 $12 Million - $14 Million	405,636 Added 786.71%	457,197 $14.4 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $1.76 Million - $1.87 Million	51,561 New	51,561 $0

Others Institutions Holding ELAN

# of Institutions

420

Shares Held

487M

Call Options Held

868K

Put Options Held

1.42M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $9.8B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Elanco Animal Health Inc Transaction History